The principal urinary 17-ketosteroids (17KS) were analyzed in 16 cases of hirsutism; their conjugated forms were separately cleaved, and the liberated 17KS were chromatographed and quantitated. Six were clinically classified as cases of Stein-Leventhal syndrome and the remaining 10 as "idiopathic hirsutism." 1 The following conditions were excluded a priori: adrenal and ovarian tumors, Cushing's disease, and congenital adrenal hyperplasia.
The principal urinary 17-ketosteroids (17KS) were analyzed in 16 cases of hirsutism; their conjugated forms were separately cleaved, and the liberated 17KS were chromatographed and quantitated. Six were clinically classified as cases of Stein-Leventhal syndrome and the remaining 10 as "idiopathic hirsutism." 1 The following conditions were excluded a priori: adrenal and ovarian tumors, Cushing's disease, and congenital adrenal hyperplasia.
Determination of total urinary 17KS in idiopathic hirsutism or in the Stein-Leventhal syndrome has not disclosed conclusive information regarding either the etiology or the pathologic physiology responsible for the appearance of hirsutism in these patients. On the other hand, fractionation of the urinary 17KS has revealed two types of urinary steroid abnormalities in hirsute patients. One abnormality is manifest primarily as an increase in urinary dehydroisoandrosterone 2 both before and after administration of ACTH (2) . The second abnormality is an increased urinary level of androsterone and etiocholanolone. In the latter instance some authors have suggested that the adrenal is responsible for the precursors of the increased androsterone and etiocholanolone (3) (4) (5) (6) (7) , although others have suggested an ovarian origin and still others could not discern the glandular origin of these steroids (8) (9) (10) . A significant residual level of urinary 17KS after adrenal suppression following administration of analogs of cortisol (11) (12) (13) (14) (15) favors an ovarian origin of the precursors responsible for the elevation of the androsterone and etiocholanolone values reported.
Since the highest blood concentrations of 17KS are represented by those steroids conjugated with sulfuric acid (16) , we have restudied the urinary steroids in hirsutism, particularly in order to quantitate the sulfates of 17KS and to discern whether these values more truly reflect the metabolic alteration involved.
METHODS
Techniques of determination. In order to avoid spontaneous hydrolysis of the conjugated steroids, the 24-hour urine collections were treated with 2 ml of 1 per cent mercurithiosalicylic acid and 5 ml of butanol. The urines were processed immediately or stored at -10°C in the freezer until they could be analyzed.
Total 17KS was measured by the method of Jayle, Crepy and Scholler (17) . Cleavage of the 17KS conjugates was carried out according to a previously published method (18) which completely separates the glucuronoside from the sulfate fractions by first utilizing the solvolysis technique of Burstein and Lieberman for the 17KS sulfates (19) . The 17KS glucuronosides were extracted from ethyl acetate with 1 N NaOH and were subsequently submitted to enzymatic hydrolysis with Helix Pomatia (L) #-glucuronidase (18) . Liberated steroids were chromatographed on the ligroin-propanediol and the hexane: benzene (1: 1) -propanediol systems on a single sheet of paper. The 17KS were located and measured by the Zimmermann reaction. The variation of recovery was ± 20 per cent. The chromatographic separation of dehydroisoandrosterone by this method was adequate, whereas androsterone and etiocholanolone traveled close to 3,-etiocholanolone and isoandrosterone, respectively. We have verified by adsorption chromatography and infrared spectrophotometry that these compounds do not account for more than 5 per cent of the total in the case of 3#-etiocholanolone, and 25 per cent in the case of isoandrosterone in normal and abnormal cases.
The 17-hydroxycorticosteroids were measured by the Porter-Silber method as modified by Scholler, Busigny and Jayle (20 Table II , were ambulatory.
The six cases of Stein-Leventhal syndrome were confirmed at laparotomy and by pathological examination of the removed ovarian wedges, as well as by resumption of ovulatory menses after wedge resection of the ovaries (1-6) ( Table II) ; all of the patients with Stein-Leventhal syndrome presented some degree of hirsutism. Some of the patients classified as having "idiopathic hirsutism" (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) had menstrual abnormalities, but none of this group had enlarged ovaries. A 24-hour urine specimen served as a control in each patient studied.
Adrenal suppression was effected by the administration of dexamethasone, 1 mg three times a day for 12 days.
On days 6, 7, and 8 of adrenal suppression, 5,000 U of chorionic gonadotrophin3 was administered intramuscularly each day. Urine was collected on day 12 of this regimen.
In addition to the regimen of adrenal suppression and ovarian stimulation, three patients (one with Stein-Leventhal syndrome and two with idiopathic hirsutism) were studied after the intravenous infusion of 25 mg ACTH administered over an 8-hour period. (Figure 1 ). In the glucuronoside fraction, the etiocholanolone/ androsterone ratio was essentially the same.
Also listed in Table I ferences, we should like to call attention to the pattern of etiocholanolone and androsterone sulfates; unlike the women, every man had higher values of androsterone sulfate than of etiocholanolone sulfate. However, the etiocholanolone/androsterone ratio was still greater than 1 in the glucoronoside fraction.
In other words, the etiocholanolone/androsterone ratio is definitely lower in the urine of normal males than of normal females and, moreover, levels of androsterone sulfate are consistently higher in the urine of males than of females.
2) Adrenal suppression and ovarian stimulation. The normal women, after adrenal suppression and ovarian stimulation, had 17-hydroxy- (Tables II and III ; Figures  1 and 2 ). The mean of the total 17KS was higher in both groups of patients than in the normal women studied; the individual levels of androsterone, etiocholanolone, dehydroisoandrosterone, and the 11-oxy-17KS, when measured separately, were increased, but the degree of their elevation showed considerable variation.
When the 16 patients were considered as one group, the following observations were made. The most striking and consistent abnormality was found in the androsterone and etiocholanolone fractions. As glucuronosides, the androsterone was slightly more elevated (200 per cent) than the etiocholanolone (150 per cent). The sulfate fractions were more prominently elevated-androsterone 800 and etiocholanolone 300 per cent. The most impressive anomalies resided in the increase in the sulfate fraction as a whole (p > 0.001) over the glucuronoside fraction (p = 0.1; Table III ) and in the increase of androsterone (primarily as sulfate) over etiocholanolone.
The results in the six Stein-Leventhal patients were similar, but not identical: the increase in dehydroisoandrosterone in these six patients was not so marked as in the group as a whole, but was consistently elevated, and the elevation was statistically significant (p = 0.001). Again, however, the most remarkable finding was the marked increase in the androsterone and etiocholanolone sulfates (> 500 per cent).
It is interesting to note the similarity between the urinary 17KS patterns of hirsute women and normal men.
2) ACTH (Table IV) . Similar urinary studies were carried out after the administration of ACTH to one patient with the Stein-Leventhal syndrome and to two patients with idiopathic hirsutism. In all three patients there was a significant increase in androsterone and etiocholano- lone glucuronosides, as well as in dehydroisoandrosterone sulfate and the 11-oxy-17KS glucuronosides. On the other hand, androsterone and etiocholanolone sulfates remained virtually unchanged.
3) Adrenal suppression and ovarian stimulation (Table V; Figures 1 and 2) . After combined adrenal suppression and ovarian stimulation, the six patients with Stein-Leventhal syndrome exhibited a significant level of androsterone and etiocholanolone which confirmed the previous findings of Jayle and colleagues (14) . Both glucuronoside and sulfate forms of the steroids were present. In these experiments dehydroisoandrosterone (not included in Table V) was totally absent, as it was in the normal women examined under these conditions.
The seven cases of idiopathic hirsutism studied by this method, however, had virtually no urinary androsterone or etiocholanolone sulfate (except Patient 9) and may be distinguished from the cases of Stein-Leventhal syndrome by this criterion. At the same time, androsterone and etiocholanolone glucuronosides were present in significant (Patients 7-9) or markedly decreased amounts (Patients 10-13). Dehydroisoandrosterone was absent in this group also. The phenolsteroids, pregnanediol, and pregnanetriol determinations in Patients 7 and 8 may suggest "ovarian hyperthecosis" (14) .
One further finding appeared in the patients with Stein-Leventhal syndrome. As shown in Table V and Figure 1 , the androsterone/etiocholanolone glucuronosides ratio after dexamethasone-HCG administration was not altered, whereas the value for etiocholanolone sulfate was greater than that for androsterone sulfate in all except Patient 5. This finding appears more significant when one notes that, before the test, androsterone sulfate was as high or higher (except in Patient 2) than was etiocholanolone sulfate.
This preponderance of etiocholanolone is not easily explainable and the administration of dexamethasone as well as the pathological condition may be the cause.
To summarize the findings, after adrenal suppression by dexamethasone and ovarian stimulation by chorionic gonadotrophin in patients with hirsutism, there was significantly more androsterone and etiocholanolone than was present in the normal female under the same conditions. In idiopathic hirsutism the sulfate-17KS have completely disappeared. In the Stein-Leventhal syndrome, however, androsterone and etiocholanolone sulfates remained at a relatively high level, with the etiocholanolone sulfate value exceeding that of the androsterone sulfate. DISCUSSION A) Under experimental conditions employed for the independent measurement of the sulfate-17KS and glucuronoside-17KS (18), any free urinary 17KS would be measured as sulfates, but free 17KS are practically absent in human urine (<0.05 mg per 24-hour urine); it is unlikely that the increased values of sulfate could be attributed here to 8-glucuronidase present in the urine (21) . First, the levels of sulfate-17KS observed were greater than could be expected from the hydrolysis of steroid glucuronosides by mammalian f8-glucuronidase. Furthermore, the androsterone/etiocholanolone ratio was different in the sulfate fraction when compared with the androsterone/etiocholanolone ratio in the glucuronoside fraction. In addition, the increased urinary excretion of sulfoconjugated androsterone and etiocholanolone -is indirectly confirmed by the increased blood levels of these compounds found in some of the patients and then isolated from plasma as the conjugates (22) . B) In patients exhibiting the Stein-Leventhal syndrome, the findings establish a definitive pattern of urinary steroid metabolites. All patients with Stein-Leventhal syndrome were subjected to laparotomy and each had a typically enlarged, pale, smooth-surfaced polycystic ovary characteristic of the disease. Concomitant with these pathological findings were elevations of androsterone and etiocholanolone sulfates in the control urine, with androsterone sulfate frequently being the preponderant fraction. In addition, there was persistent elevation of these sulfates to the extent of more than 0.7 mg per 24 hours after adrenal suppression and HCG stimulation, but now with a shift to etiocholanolone sulfate dominance. These findings permitted a laboratory diagnosis prior to and substantiated by laparotomy.
In the cases of idiopathic hirsutism, an increase in androsterone sulfate and etiocholanolone 1695 sulfate was found during the control period which, as not with the Stein-Leventhal patients, virtually disappeared after dexamethasone-gonadotrophin treatment. This finding, combined with the difference in ovarian morphology, provided a point of distinction between patients with Stein-Leventhal syndrome and those with idiopathic hirsutism.
The persistence of more than 2 mg of androsterone and etiocholanolone glucuronosides in Patients 7-9 after the combined treatment suggested an ovarian precursor(s) for these metabolites.
C) In certain patients, dehydroisoandrosterone was significantly elevated. The ovarian origin of dehydroisoandrosterone, in pathological conditions at least, has been suggested recently by isolation of dehydroisoandrosterone from ovarian tissue (22, 23) , by experiments in vitro in which dehydroisoandrosterone was synthesized from acetate (24) or A5-pregnenolone (25) , in metabolic studies in which the secretory rate of dehydroisoandrosterone was determined after adrenal suppression (26) , and in studies of plasma dehydroisoandrosterone sulfate levels in SteinLeventhal syndrome (27) .
In the cases reported here, however, urinary dehydroisoandrosterone was not detected after adrenal suppression and ovarian stimulation, and this is consistent with the assertion that dehydroisoandrosterone is only of adrenal origin. However, this assumption is based on a constancy of conversion of dehydroisoandrosterone to urinary sulfate of dehydroisoandrosterone, which may not be true (28) . D) In Stein-Leventhal syndrome as well as in idiopathic hirsutism, it is difficult to ascertain whether the etiology of hirsutism is of adrenal or ovarian origin. New findings favoring the ovarian origin of dehydroisoandrosterone have been cited above. In addition, it has recently been shown by techniques in vitro that the Stein-Leventhal ovaries may produce increased amounts of androstenedione, or testosterone, or both (23, 25, (29) (30) (31) (32) . Recent work suggests that the secretion of small amounts of a potent androgen such as androstenedione or testosterone may induce significant virilization without concomitantly contributing to a significant increase in total urinary 17KS (33) .
The results herein presented also favor the ovarian origin of a steroid that might cause hirsutism. During adrenal suppression, which was sufficient to decrease the 11-oxy-17KS and dehydroisoandrosterone of adrenal origin, the concomitant administration of HCG resulted in significant levels of androsterone and etiocholanolone in the urine in addition to increased levels of phenolic steroids under the same conditions (15) . But this does not mean that ovarian steroid biosynthesis is the only abnormality in hirsutism. The slight, but significant elevation in 11-oxygenated 17KS also suggests an adrenal disorder. E) Several explanations may be offered regarding the increased 17KS-sulfates. First (35) .
F) The relationship between plasma and urinary levels of 17KS-sulfates will be considered elsewhere (22) . The existence of a cause and effect correlation between hirsutism and 17KS-sulfates must, at the present time, be left to speculation. The apparent absence of hydrolysis in vivo of androsterone sulfate and etiocholanolone sulfate (36) leads us to assume that their urinary levels reflect their endogenous production.
SUMMARY
Six cases of Stein-Leventhal syndrome and ten cases of "idiopathic hirsutism" have been studied. The urinary 17-ketosteroids (17KS) have been separated as sulfoconjugated and glucuronoconjugated forms, and the free steroids derived from each conjugated group have been fractionated and measured after paper chromatography.
In the Stein-Leventhal syndrome, androsterone and etiocholanolone were significantly elevated, with androsterone showing the more marked elevation. In addition, the sulfate of androsterone and the sulfate of etiocholanolone were more increased than the corresponding glucuronosides.
Dehydroisoandrosterone (sulfoconj ugated) was constantly and significantly elevated, whereas the 11-oxygenated 17KS (glucuronoconjugated) were only slightly increased.
After concomitant dexamethasone and chorionic gonadotrophin administration, dehydroisoandrosterone and 11-oxygenated 17KS were not detectable, but abnormally high levels of androsterone and etiocholanolone, especially of androsterone and etiocholanolone sulfates, persisted, with etiocholanolone sulfate predominating.
In idiopathic hirsutism, androsterone and etiocholanolone sulfates, particularly the former, were elevated, but disappeared after adrenal suppression and ovarian stimulation. After this test, androsterone and etiocholanolone glucuronosides were variable. In the untreated patients with idiopathic hirsutism, dehydroisoandrosterone and 11-oxygenated 17KS were variable, and were not detectable after dexamethasone administration.
The usefulness of these findings as a diagnostic test and their implication in the pathogenesis of these conditions have been discussed.
